Orris

Classify Acute kidney injury. Write a notes on this topic for my MD Anaesthesiology exam notes

Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File

Acute Kidney Injury (AKI) — Notes for MD Anaesthesiology

1. Definition

AKI (previously "acute renal failure") is an abrupt (within 48 hours to 7 days) decline in glomerular filtration rate (GFR) with accumulation of nitrogenous waste products (urea, creatinine) and disturbance of fluid, electrolyte, and acid-base homeostasis. It occurs in 5-25% of hospitalized patients and up to 50-80% mortality in ICU settings when severe (Miller's Anesthesia, 10e).

2. Classification of AKI

A. By Staging/Severity Criteria (most important for exams)

Three consensus classification systems have evolved sequentially — RIFLE → AKIN → KDIGO. KDIGO (2012) is now the standard.
RIFLE Criteria (2004, ADQI) — acronym for severity + outcome:
CategoryGFR/Creatinine CriteriaUrine Output
Risk↑ SCr ×1.5-2 or GFR fall >25%<0.5 mL/kg/h × 6h
Injury↑ SCr ×2-3 or GFR fall >50%<0.5 mL/kg/h × 12h
Failure↑ SCr ×3 or SCr ≥4 mg/dL (acute rise ≥0.5) or GFR fall >75%<0.3 mL/kg/h × 24h or anuria ×12h
LossPersistent ARF = complete loss of renal function >4 weeks-
ESKDEnd-stage kidney disease >3 months-
AKIN Criteria (2007) — modified RIFLE, added an absolute rise in creatinine (≥0.3 mg/dL) to capture even small changes, and dropped the two outcome categories (Loss, ESKD), keeping only 3 stages:
  • Stage 1: SCr ↑ ≥0.3 mg/dL or ≥1.5-2 fold from baseline; UO <0.5 mL/kg/h ×6h
  • Stage 2: SCr ↑ 2-3 fold; UO <0.5 mL/kg/h ×12h
  • Stage 3: SCr ↑ >3 fold or SCr ≥4 mg/dL with acute rise ≥0.5 mg/dL, or initiation of renal replacement therapy (RRT); UO <0.3 mL/kg/h ×24h or anuria ×12h
KDIGO Criteria (2012) — current gold standard, combines RIFLE and AKIN.
Definition of AKI (any one of):
  • Rise in SCr by ≥0.3 mg/dL (≥26.5 µmol/L) within 48 hours, or
  • Rise in SCr to ≥1.5 times baseline, known or presumed to have occurred within prior 7 days, or
  • Urine volume <0.5 mL/kg/h for 6 hours
Staging:
StageSerum CreatinineUrine Output
11.5-1.9× baseline OR ≥0.3 mg/dL absolute rise<0.5 mL/kg/h for 6-12 h
22.0-2.9× baseline<0.5 mL/kg/h for ≥12 h
33× baseline OR SCr ≥4.0 mg/dL OR initiation of RRT OR (in patients <18 yrs) eGFR <35 mL/min/1.73m²<0.3 mL/kg/h for ≥24 h OR anuria for ≥12 h
(Source: Table 31-3, Morgan and Mikhail's Clinical Anesthesiology, 7e; Table 38.1, Miller's Anesthesia, 10e)
Key teaching point for exam: KDIGO stage is defined by whichever criterion (creatinine or urine output) gives the higher/worse stage. Milder AKI (KDIGO stage 1) is far more common than stage 3 and carries proportionately lower mortality — even small creatinine rises are associated with increased mortality risk, which is why the newer criteria are more sensitive than the old "postoperative dialysis requirement" definition.

B. By Anatomical/Etiological Site (classical surgical/anaesthesia classification)

  1. Prerenal AKI (~55-60%, most common in perioperative setting)
    • Due to renal hypoperfusion without intrinsic parenchymal damage; reversible if corrected early
    • Causes: hypovolemia (hemorrhage, GI loss, third-spacing), decreased cardiac output (CHF, cardiogenic shock), systemic vasodilation (sepsis, anaphylaxis, anesthetic-induced vasodilation), renal vasoconstriction (NSAIDs, ACE-I/ARB with volume depletion, hepatorenal syndrome), intraoperative hypotension from anesthetic agents (negative inotropy/chronotropy, vasodilation)
  2. Intrinsic (Intrarenal) AKI (~35-40%)
    • Acute Tubular Necrosis (ATN) — most common intrinsic cause perioperatively; two primary mechanisms:
      • Ischemia-reperfusion injury (prolonged prerenal insult progressing to ATN)
      • Nephrotoxic injury — contrast media, aminoglycosides, NSAIDs, myoglobin (rhabdomyolysis), hemoglobin (hemolysis/transfusion reaction), cisplatin
    • Acute interstitial nephritis (drug-induced — penicillins, NSAIDs, PPIs)
    • Glomerulonephritis/vasculitis
    • Vascular causes: atheroembolism, renal artery/vein thrombosis
    • Common perioperative insults: hypoperfusion, inflammation (SIRS/sepsis, cardiopulmonary bypass), and atheroembolism
  3. Postrenal AKI (~5-10%)
    • Obstruction to urine flow — ureteric (stones, tumor, retroperitoneal fibrosis), bladder outlet (BPH, blood clot, neurogenic bladder), urethral (stricture, blocked catheter)
    • Important to exclude first (bladder scan/USG) since it is rapidly reversible

C. By Course/Duration

  • AKI: dysfunction <7 days
  • Acute Kidney Disease (AKD): 7-90 days
  • Chronic Kidney Disease (CKD): >90 days

3. Pathophysiology (ATN phases — relevant to understand recovery)

  1. Initiation phase: renal blood flow ↓ → ATP depletion or toxin-induced injury; cytokine upregulation begins
  2. Extension phase: necrosis/apoptosis progress, GFR continues to fall; inflammatory infiltration peaks — this is the window for therapeutic intervention
  3. Maintenance phase: blood flow normalizes, GFR stabilizes, cellular repair begins
  4. Recovery phase: tubular epithelial redifferentiation, restoration of function
(Source: Brenner and Rector's The Kidney, 2-Vol Set)

4. Perioperative/Anaesthesia-Specific Points (high-yield for MD Anaesthesiology)

Risk factors (Fig 38.1, Miller's Anesthesia):
  • Preoperative: pre-existing CKD, diabetes, advanced age, heart failure, jaundice, anemia, contrast exposure
  • Intraoperative: hypotension, hypovolemia, high-risk surgery (cardiac, aortic, major vascular), prolonged aortic cross-clamping, cardiopulmonary bypass, nephrotoxic drug exposure, rhabdomyolysis
  • Postoperative: sepsis, ongoing hypoperfusion, nephrotoxin continuation
Anesthetic drug considerations:
  • Compound A (sevoflurane breakdown product with low-flow anesthesia + soda lime) — nephrotoxic in animal models; clinical significance in humans is debated (Morgan & Mikhail, Key Concepts)
  • Both general and neuraxial anesthesia reversibly reduce renal blood flow, GFR, urine flow, and sodium excretion — AKI is less likely purely from anesthesia itself than from surgical/hemodynamic insults
  • Morphine (morphine-6-glucuronide) and meperidine (normeperidine) metabolites accumulate in renal failure → prolonged respiratory depression; normeperidine can cause seizures
  • Succinylcholine is safe in renal failure provided no baseline hyperkalemia
  • Controlled ventilation preferred in renal failure patients under GA — avoid hypercarbia/respiratory acidosis which worsens hyperkalemia and acidemia
  • Delayed gastric emptying (uremic autonomic neuropathy) → aspiration risk
Diagnostic workup (Table, Morgan & Mikhail):
TestStrengthWeakness
Serum creatinineCheap, availableLate marker, confounded by muscle mass/fluid status
BUNCheap, availableConfounded by GI bleed, liver disease, hypovolemia
FeNaCheapUnreliable with diuretics/CKD
Urine microscopyNon-invasive, informative (e.g., RBC casts in GN)Operator-dependent
Novel biomarkers (NGAL, KIM-1, TIMP-2, IGFBP7, IL-18)Detect AKI before creatinine riseCostly, not routine
Management principles: identify and treat the underlying cause (correct hypovolemia/hypotension first, relieve obstruction, stop nephrotoxins), optimize renal perfusion pressure, avoid further nephrotoxic insults (contrast, NSAIDs, aminoglycosides), maintain euvolemia (avoid both under- and over-resuscitation), treat hyperkalemia/acidosis, and initiate RRT when indicated (refractory hyperkalemia, fluid overload, severe acidosis, uremic complications, or per KDIGO stage 3 criteria).
A quick check of recent evidence for updates on perioperative AKI definitions did not surface any change contradicting the KDIGO framework above — KDIGO remains the current standard used in anesthesia literature (Miller's Anesthesia 10e, 2024 edition already reflects this).
For your exam, the classic short-answer/table expected is the RIFLE vs AKIN vs KDIGO comparison table plus the prerenal-intrinsic-postrenal etiological classification — examiners frequently ask you to draw this out and then discuss perioperative risk factors and anesthetic implications, which are covered above.

While making pdf plz maintain riffle criteria in a proper chart

Reading File
Browsing Directory

/tmp/workspace

Running Command

mkdir -p /tmp/workspace/aki-notes && cat > /tmp/workspace/aki-notes/make_pdf.py << 'EOF' from reportlab.lib.pagesizes import A4 from reportlab.lib.units import cm from reportlab.lib import colors from reportlab.platypus import (SimpleDocTemplate, Paragraph, Spacer, Table, TableStyle, PageBreak, ListFlowable, ListItem) from reportlab.lib.styles import getSampleStyleSheet, ParagraphStyle from reportlab.lib.enums import TA_CENTER, TA_LEFT doc = SimpleDocTemplate("/tmp/workspace/aki-notes/AKI_Classification_Notes_MD_Anaesthesiology.pdf", pagesize=A4, topMargin=1.5*cm, bottomMargin=1.5*cm, leftMargin=1.5*cm, rightMargin=1.5*cm) styles = getSampleStyleSheet() title_style = ParagraphStyle('TitleX', parent=styles['Title'], fontSize=18, spaceAfter=4, textColor=colors.HexColor('#1a3c6e')) subtitle_style = ParagraphStyle('SubtitleX', parent=styles['Normal'], fontSize=11, textColor=colors.HexColor('#555555'), spaceAfter=14) h1 = ParagraphStyle('H1', parent=styles['Heading1'], fontSize=14, textColor=colors.HexColor('#1a3c6e'), spaceBefore=14, spaceAfter=6) h2 = ParagraphStyle('H2', parent=styles['Heading2'], fontSize=12, textColor=colors.HexColor('#2a5a9c'), spaceBefore=10, spaceAfter=4) body = ParagraphStyle('Body', parent=styles['Normal'], fontSize=10, leading=14, spaceAfter=6, alignment=TA_LEFT) bullet_style = ParagraphStyle('Bullet', parent=styles['Normal'], fontSize=10, leading=13.5, leftIndent=12, spaceAfter=3) small_note = ParagraphStyle('SmallNote', parent=styles['Normal'], fontSize=8.5, leading=11, textColor=colors.HexColor('#444444'), spaceAfter=6) table_cell = ParagraphStyle('TableCell', parent=styles['Normal'], fontSize=8.5, leading=10.5) table_header = ParagraphStyle('TableHeader', parent=styles['Normal'], fontSize=9, leading=11, textColor=colors.white, alignment=TA_CENTER, fontName='Helvetica-Bold') table_stagecell = ParagraphStyle('StageCell', parent=styles['Normal'], fontSize=9, leading=11, fontName='Helvetica-Bold', alignment=TA_CENTER) elements = [] elements.append(Paragraph("Acute Kidney Injury (AKI)", title_style)) elements.append(Paragraph("Classification &amp; Notes for MD Anaesthesiology Exam", subtitle_style)) # ---------------- 1. Definition ---------------- elements.append(Paragraph("1. Definition", h1)) elements.append(Paragraph( "AKI (previously 'acute renal failure') is an abrupt decline (within 48 hours to 7 days) in glomerular " "filtration rate (GFR), with accumulation of nitrogenous waste products (urea, creatinine) and disturbance " "of fluid, electrolyte, and acid-base homeostasis. It occurs in 5-25% of hospitalized patients, with " "mortality up to 50-80% in ICU settings when severe. <i>(Miller's Anesthesia, 10e)</i>", body)) # ---------------- 2. Classification ---------------- elements.append(Paragraph("2. Classification of AKI", h1)) elements.append(Paragraph("A. By Staging / Severity Criteria — RIFLE, AKIN, KDIGO", h2)) elements.append(Paragraph( "Three consensus staging systems evolved sequentially: <b>RIFLE (2004) &#8594; AKIN (2007) &#8594; KDIGO (2012)</b>. " "KDIGO is now the current standard used in anaesthesia and critical care practice.", body)) elements.append(Paragraph("RIFLE Criteria (Risk, Injury, Failure, Loss, End-stage kidney disease)", h2)) rifle_data = [ [Paragraph("Category", table_header), Paragraph("Serum Creatinine / GFR Criteria", table_header), Paragraph("Urine Output Criteria", table_header)], [Paragraph("<b>R</b> - Risk", table_stagecell), Paragraph("&#8593; SCr &#215;1.5-2 from baseline, or GFR fall &gt;25%", table_cell), Paragraph("&lt;0.5 mL/kg/h &#215; 6 h", table_cell)], [Paragraph("<b>I</b> - Injury", table_stagecell), Paragraph("&#8593; SCr &#215;2-3 from baseline, or GFR fall &gt;50%", table_cell), Paragraph("&lt;0.5 mL/kg/h &#215; 12 h", table_cell)], [Paragraph("<b>F</b> - Failure", table_stagecell), Paragraph("&#8593; SCr &#215;3 from baseline, or SCr &#8805;4 mg/dL (with acute rise &#8805;0.5 mg/dL), or GFR fall &gt;75%", table_cell), Paragraph("&lt;0.3 mL/kg/h &#215; 24 h, or anuria &#215; 12 h", table_cell)], [Paragraph("<b>L</b> - Loss", table_stagecell), Paragraph("Persistent ARF = complete loss of renal function &gt; 4 weeks", table_cell), Paragraph("-", table_cell)], [Paragraph("<b>E</b> - ESKD", table_stagecell), Paragraph("End-stage kidney disease &gt; 3 months", table_cell), Paragraph("-", table_cell)], ] rifle_table = Table(rifle_data, colWidths=[3.2*cm, 8.8*cm, 4.5*cm]) rifle_table.setStyle(TableStyle([ ('BACKGROUND', (0,0), (-1,0), colors.HexColor('#1a3c6e')), ('BACKGROUND', (0,1), (-1,1), colors.HexColor('#eaf1fb')), ('BACKGROUND', (0,2), (-1,2), colors.HexColor('#d4e4f7')), ('BACKGROUND', (0,3), (-1,3), colors.HexColor('#b8d3f0')), ('BACKGROUND', (0,4), (-1,4), colors.HexColor('#f5f5f5')), ('BACKGROUND', (0,5), (-1,5), colors.HexColor('#e8e8e8')), ('GRID', (0,0), (-1,-1), 0.75, colors.HexColor('#8ca6c9')), ('VALIGN', (0,0), (-1,-1), 'MIDDLE'), ('ALIGN', (0,0), (0,-1), 'CENTER'), ('TOPPADDING', (0,0), (-1,-1), 5), ('BOTTOMPADDING', (0,0), (-1,-1), 5), ('LEFTPADDING', (0,0), (-1,-1), 6), ('RIGHTPADDING', (0,0), (-1,-1), 6), ])) elements.append(rifle_table) elements.append(Paragraph("<i>RIFLE = Risk, Injury, Failure, Loss, End-stage kidney disease (Acute Dialysis Quality Initiative, 2004)</i>", small_note)) elements.append(Paragraph("Comparison: RIFLE vs AKIN vs KDIGO Staging", h2)) cmp_data = [ [Paragraph("", table_header), Paragraph("RIFLE", table_header), Paragraph("AKIN", table_header), Paragraph("KDIGO", table_header), Paragraph("Urine Output<br/>(common to all)", table_header)], [Paragraph("Definition of AKI", table_stagecell), Paragraph("As per Risk criterion below", table_cell), Paragraph("&#8593; SCr &#8805;0.3 mg/dL (&#8805;26.4 &#181;mol/L) OR &#8805;50% (1.5-fold) rise in 48 h", table_cell), Paragraph("&#8593; SCr &#8805;26.5 &#181;mol/L in &#8804;48 h, OR &#8805;1.5&#215; baseline within prior 7 days", table_cell), Paragraph("-", table_cell)], [Paragraph("Stage 1", table_stagecell), Paragraph("<b>Risk:</b> SCr &#215;1.5-2, or GFR fall &gt;25%", table_cell), Paragraph("SCr &#8593; &#8805;0.3 mg/dL or &#215;1.5-2 baseline", table_cell), Paragraph("SCr &#215;1.5-1.9 baseline OR &#8593; &#8805;0.3 mg/dL", table_cell), Paragraph("&lt;0.5 mL/kg/h &#215; 6-12 h", table_cell)], [Paragraph("Stage 2", table_stagecell), Paragraph("<b>Injury:</b> SCr &#215;2-3, or GFR fall &gt;50%", table_cell), Paragraph("SCr &#215;2-3 baseline", table_cell), Paragraph("SCr &#215;2.0-2.9 baseline", table_cell), Paragraph("&lt;0.5 mL/kg/h &#215; &#8805;12 h", table_cell)], [Paragraph("Stage 3", table_stagecell), Paragraph("<b>Failure:</b> SCr &#215;3, or SCr &#8805;4 mg/dL (acute &#8593;&#8805;0.5), or GFR fall &gt;75%", table_cell), Paragraph("SCr &#215;&gt;3 baseline, or SCr &#8805;4 mg/dL, or RRT initiated", table_cell), Paragraph("SCr &#215;3.0 baseline, or SCr &#8805;4.0 mg/dL, or RRT initiated", table_cell), Paragraph("&lt;0.3 mL/kg/h &#215; &#8805;24 h, or anuria &#8805;12 h", table_cell)], [Paragraph("Outcome<br/>categories", table_stagecell), Paragraph("<b>Loss</b> (&gt;4 wk), <b>ESKD</b> (&gt;3 mo)", table_cell), Paragraph("Not included", table_cell), Paragraph("Not included", table_cell), Paragraph("-", table_cell)], ] cmp_table = Table(cmp_data, colWidths=[2.2*cm, 4.0*cm, 3.7*cm, 3.7*cm, 2.9*cm]) cmp_table.setStyle(TableStyle([ ('BACKGROUND', (0,0), (-1,0), colors.HexColor('#1a3c6e')), ('BACKGROUND', (0,1), (-1,1), colors.HexColor('#fdf3d6')), ('BACKGROUND', (0,2), (-1,2), colors.HexColor('#eaf1fb')), ('BACKGROUND', (0,3), (-1,3), colors.HexColor('#d4e4f7')), ('BACKGROUND', (0,4), (-1,4), colors.HexColor('#b8d3f0')), ('BACKGROUND', (0,5), (-1,5), colors.HexColor('#f5f5f5')), ('GRID', (0,0), (-1,-1), 0.75, colors.HexColor('#8ca6c9')), ('VALIGN', (0,0), (-1,-1), 'MIDDLE'), ('ALIGN', (0,0), (0,-1), 'CENTER'), ('TOPPADDING', (0,0), (-1,-1), 5), ('BOTTOMPADDING', (0,0), (-1,-1), 5), ('LEFTPADDING', (0,0), (-1,-1), 5), ('RIGHTPADDING', (0,0), (-1,-1), 5), ('FONTSIZE', (0,0), (-1,-1), 8), ])) elements.append(cmp_table) elements.append(Paragraph( "<i>AKIN dropped RIFLE's Loss/ESKD categories but added sensitivity for small absolute creatinine rises " "(&#8805;0.3 mg/dL). KDIGO (current standard) merges RIFLE and AKIN, using whichever of creatinine or urine " "output gives the worse stage. (Table 31-3, Morgan &amp; Mikhail's Clinical Anesthesiology, 7e; Table 38.1, " "Miller's Anesthesia, 10e)</i>", small_note)) elements.append(Paragraph( "<b>Exam tip:</b> KDIGO stage is assigned by whichever criterion (creatinine OR urine output) gives the " "higher/worse stage. Milder AKI (Stage 1) is far more common than Stage 3 and carries lower mortality - " "but even small creatinine rises independently increase mortality risk, which is why sensitive criteria " "replaced the older 'need for dialysis' definition.", body)) # ---------------- B. Etiological classification ---------------- elements.append(Paragraph("B. By Anatomical / Etiological Site", h2)) elements.append(Paragraph("<b>1. Prerenal AKI (~55-60%)</b> - most common perioperatively; due to renal hypoperfusion without parenchymal damage, reversible if corrected early.", body)) prerenal_items = [ "Hypovolemia: hemorrhage, GI losses, third-spacing", "Decreased cardiac output: CHF, cardiogenic shock", "Systemic vasodilation: sepsis, anaphylaxis, anesthetic-induced vasodilation", "Renal vasoconstriction: NSAIDs, ACE-I/ARB with volume depletion, hepatorenal syndrome", "Intraoperative hypotension from anesthetic agents (negative inotropy/chronotropy + vasodilation)", ] elements.append(ListFlowable([ListItem(Paragraph(x, bullet_style)) for x in prerenal_items], bulletType='bullet', start='circle', leftIndent=18)) elements.append(Paragraph("<b>2. Intrinsic (Intrarenal) AKI (~35-40%)</b>", body)) intrinsic_items = [ "Acute Tubular Necrosis (ATN) - commonest intrinsic cause perioperatively; from ischemia-reperfusion injury or nephrotoxic injury (contrast, aminoglycosides, NSAIDs, myoglobin from rhabdomyolysis, hemoglobin from hemolysis/transfusion reaction, cisplatin)", "Acute interstitial nephritis (drug-induced - penicillins, NSAIDs, PPIs)", "Glomerulonephritis / vasculitis", "Vascular causes: atheroembolism, renal artery/vein thrombosis", "Common perioperative triggers: hypoperfusion, inflammation (sepsis/SIRS, CPB), atheroembolism", ] elements.append(ListFlowable([ListItem(Paragraph(x, bullet_style)) for x in intrinsic_items], bulletType='bullet', start='circle', leftIndent=18)) elements.append(Paragraph("<b>3. Postrenal AKI (~5-10%)</b> - obstruction to urine flow; important to exclude first (bladder scan/USG KUB) as it is rapidly reversible.", body)) postrenal_items = [ "Ureteric: stones, tumor, retroperitoneal fibrosis", "Bladder outlet: BPH, blood clot, neurogenic bladder", "Urethral: stricture, blocked catheter", ] elements.append(ListFlowable([ListItem(Paragraph(x, bullet_style)) for x in postrenal_items], bulletType='bullet', start='circle', leftIndent=18)) elements.append(Paragraph("C. By Duration/Course", h2)) duration_items = [ "<b>AKI:</b> dysfunction present &lt;7 days", "<b>Acute Kidney Disease (AKD):</b> 7-90 days", "<b>Chronic Kidney Disease (CKD):</b> &gt;90 days", ] elements.append(ListFlowable([ListItem(Paragraph(x, bullet_style)) for x in duration_items], bulletType='bullet', start='circle', leftIndent=18)) elements.append(PageBreak()) # ---------------- 3. Pathophysiology ---------------- elements.append(Paragraph("3. Pathophysiology - Phases of ATN", h1)) phases = [ "<b>Initiation phase:</b> renal blood flow falls &#8594; ATP depletion or toxin-induced injury; cytokine upregulation begins.", "<b>Extension phase:</b> necrosis/apoptosis progress, GFR continues to fall; inflammatory infiltration peaks - the window for therapeutic intervention.", "<b>Maintenance phase:</b> blood flow normalizes, GFR stabilizes, cellular repair begins.", "<b>Recovery phase:</b> tubular epithelial re-differentiation, restoration of function.", ] elements.append(ListFlowable([ListItem(Paragraph(x, bullet_style)) for x in phases], bulletType='bullet', start='circle', leftIndent=18)) elements.append(Paragraph("<i>(Source: Brenner and Rector's The Kidney, 2-Volume Set)</i>", small_note)) # ---------------- 4. Anaesthesia specific ---------------- elements.append(Paragraph("4. Perioperative / Anaesthesia-Specific Points", h1)) elements.append(Paragraph("Risk Factors", h2)) rf_items = [ "<b>Preoperative:</b> pre-existing CKD, diabetes, advanced age, heart failure, jaundice, anemia, contrast exposure", "<b>Intraoperative:</b> hypotension, hypovolemia, high-risk surgery (cardiac, aortic, major vascular), prolonged aortic cross-clamp, cardiopulmonary bypass, nephrotoxic drug exposure, rhabdomyolysis", "<b>Postoperative:</b> sepsis, ongoing hypoperfusion, continued nephrotoxin exposure", ] elements.append(ListFlowable([ListItem(Paragraph(x, bullet_style)) for x in rf_items], bulletType='bullet', start='circle', leftIndent=18)) elements.append(Paragraph("<i>(Fig 38.1, Miller's Anesthesia, 10e)</i>", small_note)) elements.append(Paragraph("Anaesthetic Drug Considerations", h2)) drug_items = [ "<b>Compound A</b> (sevoflurane breakdown product with low-flow anesthesia + soda lime) - nephrotoxic in animal models; clinical significance in humans remains debated", "Both general and neuraxial anaesthesia reversibly reduce renal blood flow, GFR, urine flow and sodium excretion - AKI is less likely purely from anaesthesia itself than from surgical/hemodynamic insults", "<b>Morphine</b> (morphine-6-glucuronide) and <b>meperidine</b> (normeperidine) metabolites accumulate in renal failure &#8594; prolonged respiratory depression; normeperidine may cause seizures", "<b>Succinylcholine</b> is safe in renal failure provided no baseline hyperkalemia", "Prefer <b>controlled ventilation</b> in renal failure under GA - avoid hypercarbia/respiratory acidosis which worsens hyperkalemia and acidemia", "Delayed gastric emptying (uremic autonomic neuropathy) increases aspiration risk", ] elements.append(ListFlowable([ListItem(Paragraph(x, bullet_style)) for x in drug_items], bulletType='bullet', start='circle', leftIndent=18)) elements.append(Paragraph("<i>(Morgan and Mikhail's Clinical Anesthesiology, 7e - Key Concepts)</i>", small_note)) elements.append(Paragraph("Diagnostic Workup", h2)) diag_data = [ [Paragraph("Test", table_header), Paragraph("Strength", table_header), Paragraph("Weakness", table_header)], [Paragraph("Serum creatinine", table_cell), Paragraph("Cheap, widely available", table_cell), Paragraph("Late marker; confounded by muscle mass, fluid status, drugs", table_cell)], [Paragraph("Blood urea nitrogen", table_cell), Paragraph("Cheap, widely available", table_cell), Paragraph("Confounded by GI bleed, liver disease, hypovolemia", table_cell)], [Paragraph("FeNa", table_cell), Paragraph("Cheap, available", table_cell), Paragraph("Unreliable with diuretics or pre-existing CKD", table_cell)], [Paragraph("Urine microscopy", table_cell), Paragraph("Non-invasive; informative (e.g. RBC casts in GN)", table_cell), Paragraph("Operator-dependent, needs training", table_cell)], [Paragraph("Renal histology", table_cell), Paragraph("Definitive cause + chronicity assessment", table_cell), Paragraph("Invasive, bleeding risk", table_cell)], [Paragraph("Novel biomarkers (NGAL, KIM-1, TIMP-2, IGFBP7, IL-18)", table_cell), Paragraph("Detect AKI before creatinine rise", table_cell), Paragraph("Costly, not routine", table_cell)], ] diag_table = Table(diag_data, colWidths=[4.5*cm, 6.0*cm, 6.0*cm]) diag_table.setStyle(TableStyle([ ('BACKGROUND', (0,0), (-1,0), colors.HexColor('#1a3c6e')), ('ROWBACKGROUNDS', (0,1), (-1,-1), [colors.HexColor('#eaf1fb'), colors.white]), ('GRID', (0,0), (-1,-1), 0.75, colors.HexColor('#8ca6c9')), ('VALIGN', (0,0), (-1,-1), 'MIDDLE'), ('TOPPADDING', (0,0), (-1,-1), 5), ('BOTTOMPADDING', (0,0), (-1,-1), 5), ('LEFTPADDING', (0,0), (-1,-1), 5), ('RIGHTPADDING', (0,0), (-1,-1), 5), ('FONTSIZE', (0,0), (-1,-1), 8.5), ])) elements.append(diag_table) elements.append(Paragraph("Management Principles", h2)) mgmt_items = [ "Identify and treat the underlying cause: correct hypovolemia/hypotension, relieve obstruction, stop nephrotoxins", "Optimize renal perfusion pressure", "Avoid further nephrotoxic insults (contrast, NSAIDs, aminoglycosides)", "Maintain euvolemia - avoid both under- and over-resuscitation", "Treat hyperkalemia and metabolic acidosis", "Initiate renal replacement therapy (RRT) when indicated - refractory hyperkalemia, fluid overload, severe acidosis, uremic complications, or KDIGO Stage 3", ] elements.append(ListFlowable([ListItem(Paragraph(x, bullet_style)) for x in mgmt_items], bulletType='bullet', start='circle', leftIndent=18)) elements.append(Spacer(1, 14)) elements.append(Paragraph( "<i>Compiled from: Morgan and Mikhail's Clinical Anesthesiology 7e; Miller's Anesthesia 10e; Brenner and " "Rector's The Kidney 2-Vol Set; National Kidney Foundation Primer on Kidney Diseases 8e.</i>", small_note)) doc.build(elements) print("PDF created successfully") EOF python3 /tmp/workspace/aki-notes/make_pdf.py

Running Command

ls -la /tmp/workspace/aki-notes/

The PDF is ready with the RIFLE criteria (and the RIFLE vs AKIN vs KDIGO comparison) formatted as proper color-coded tables/charts, along with the full classification and anaesthesia-specific notes.

AKI Classification Notes MD Anaesthesiology

PDF Document · PDF

Contents:
  1. Definition of AKI
  2. Classification
    • RIFLE criteria chart (Risk/Injury/Failure/Loss/ESKD with creatinine and urine output columns)
    • RIFLE vs AKIN vs KDIGO comparison chart (stage-by-stage)
    • Etiological classification (prerenal/intrinsic/postrenal) with bullet lists
    • Duration-based classification (AKI/AKD/CKD)
  3. Pathophysiology (ATN phases)
  4. Perioperative/anaesthesia-specific notes: risk factors, anaesthetic drug considerations, diagnostic workup table, management principles
All content is sourced from Morgan & Mikhail's Clinical Anesthesiology 7e, Miller's Anesthesia 10e, Brenner and Rector's The Kidney, and the National Kidney Foundation Primer, with citations included as footnotes in the document.
This is a shared conversation. Sign in to Orris to start your own chat.